The state of point-of-care testing: a european perspective
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Point-of-care testing (POCT) refers to any diagnostic test administered outside the central laboratory at or near the location of the patient. By performing the sample collection and data analysis steps in the same location POCT cuts down on transport and processing delays, resulting in the rapid feedback of test results to medical decision-makers. Over the past decades the availability and use of POCT have steadily increased in Europe and throughout the international community. However, concerns about overall utility and the reliability of benefits to patient care have impeded the growth of POCT in some areas. While there is no agreed-upon standard for how success should be judged, the increases in speed and mobility provided by POCT can lead to substantial advantages over traditional laboratory testing. When properly utilized, POCT has been shown to yield measurable improvements in patient care, workflow efficiency, and even provide significant financial benefits. However, important organizational and quality assurance challenges must be addressed with the implementation of POCT in any health care environment. To ensure maximal benefits it may be necessary to evaluate critically and restructure existing clinical pathways to capitalize better on the rapid test turnaround times provided by POCT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Point of care testing: randomised controlled trial of clinical outcome
Kendall, J., Reeves, B., & Clancy, M. (1998) · BMJ · doi:10.1136/bmj.316.7137.1052 · Cited by 200
Mobile Device for Disease Diagnosis and Data Tracking in Resource-Limited Settings
Chin, C. D., Cheung, Y. K., Laksanasopin, T., Modena, M. M., Chin, S. Y., Sridhara, A. A., Steinmiller, D., Linder, V., Mushingantahe, J., Umviligihozo, G., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.199596 · Cited by 75 · cited 1×
“Due to its distributed nature, the cost-per-test of POCT is usually greater than tests performed in a central laboratory (23), although this is not universally true (24).”
BackgroundAsha, S. E., Chan, A. C. F., Walter, E., Kelly, P. J., Morton, R. L., Ajami, A., Wilson, R. D., & Honneyman, D. (2014) · Emergency Medicine Journal · doi:10.1136/emermed-2013-202632 · Cited by 67
Goodacre, S., Bradburn, M., Fitzgerald, P., Cross, E., Collinson, P., Gray, A., & Hall, A. (2011) · Health Technology Assessment · doi:10.3310/hta15230 · Cited by 64 · cited 3×
“Decreased TATs also can result in the earlier identification of negative cases of ACS, thereby increasing the number of successful discharges, and allowing for more efficient use of hospital resources (11).”
Background
Cited by
An artificial intelligence‐assisted diagnostic platform for rapid near‐patient hematology
Bachar, N., Benbassat, D., Brailovsky, D., Eshel, Y., Glück, D., Levner, D., Levy, S., Pecker, S., Yurkovsky, E., Zait, A., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26295 · Cited by 51
A systematic evaluation of immunoassay point-of-care testing to define impact on patients’ outcomes
Pecoraro, V., Banfi, G., Germagnoli, L., & Trenti, T. (2017) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563217694377 · Cited by 17
Metadata
- Authors
- Larsson, A., Greig-Pylypczuk, R., & Huisman, A.
- Venue
- Upsala Journal of Medical Sciences
- Publisher
- Uppsala Medical Society
- Published
- 2015-01-02
- Volume
- 120
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0300-9734 (ISSN-L)
- 2000-1967
- OpenAlex
- W2023779537
- Cited by
- 159
- References
- 4
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The state of point-of-care testing: a european perspective. https://app.cochat.ai/papers/10.3109/03009734.2015.1006347
- The paper
- Larsson, A., Greig-Pylypczuk, R., & Huisman, A. (2015). The state of point-of-care testing: a european perspective. Upsala Journal of Medical Sciences. https://doi.org/10.3109/03009734.2015.1006347
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.